Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
BACKGROUND: Studies of glycoconjugate vaccines have traditionally used an immune challenge with a plain polysaccharide vaccine to demonstrate immunologic memory. Plain polysaccharide vaccines are poorly immunogenic in children and can induce subsequent immunologic hyporesponsiveness. We therefore as...
Príomhchruthaitheoirí: | Snape, MD, Maclennan, J, Lockhart, S, English, M, Yu, L, Moxon, R, Pollard, A |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2009
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
de réir: Pace, D, et al.
Foilsithe / Cruthaithe: (2016) -
Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.
de réir: McVernon, J, et al.
Foilsithe / Cruthaithe: (2003) -
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
de réir: Micoli, F, et al.
Foilsithe / Cruthaithe: (2013) -
Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
de réir: Snape, MD, et al.
Foilsithe / Cruthaithe: (2006) -
Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
de réir: Snape, M, et al.
Foilsithe / Cruthaithe: (2006)